发明名称 1,3,5-TRIAZINE-2,4,6-TRIAMINE COMPOUND OR PHARMACEUTICAL ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
摘要 Disclosed herein are a 1,3,5-triazine-2,4,6-triamine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a composition for preventing or treating metabolic syndromes, diabetes, or cancers with deletion of P53 gene, which comprises the same.
申请公布号 WO2009028891(A3) 申请公布日期 2009.04.30
申请号 WO2008KR05062 申请日期 2008.08.28
申请人 HANALL PHARMACEUTICAL COMPANY. LTD;KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY;CHEON, HYAE GYEONG;KIM, KWANG-ROK;RHEE, SANG DAL;JUNG, WON HOON;LEE, JONG-CHEOL;KIM, SUNG WUK;JUN, SUNG SOO 发明人 CHEON, HYAE GYEONG;KIM, KWANG-ROK;RHEE, SANG DAL;JUNG, WON HOON;LEE, JONG-CHEOL;KIM, SUNG WUK;JUN, SUNG SOO
分类号 C07D251/54 主分类号 C07D251/54
代理机构 代理人
主权项
地址